Bristol-Myers Begs Court To Preserve Plavix Injunction
The injunction blocks the sale of generic Plavix until the district court reaches a decision in the patent infringement case that the three companies are currently embroiled in.
Apotex appealed the preliminary injunction to the U.S. Court of Appeals for the Federal Circuit on Sept. 6.
Bristol-Myers and Sanofi-Aventis filed their request...
To view the full article, register now.